Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Berger, Adam
Item TypeName
Concept Melanoma
Academic Article Malignant melanoma presenting as obstructive jaundice secondary to metastasis to the Ampulla of Vater.
Academic Article Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
Academic Article Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma.
Academic Article TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells.
Academic Article Altered drainage patterns in patients with melanoma and previous axillary dissection.
Academic Article Metastatic melanoma causing jejunal intussusception.
Academic Article Malignant melanoma of the gallbladder: a report of two cases and review of the literature.
Academic Article Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.
Academic Article Lymphoscintigraphy in cutaneous melanoma: an updated total body atlas of sentinel node mapping.
Academic Article Completely regressed cutaneous melanocytic lesion: was it benign or was it malignant?
Academic Article Outcomes in patients with mucosal melanomas.
Academic Article Contrast-enhanced sonography for detection of secondary lymph nodes in a melanoma tumor animal model.
Academic Article Melanoma.
Academic Article Fibroblast-derived Neuregulin 1 Promotes Compensatory ErbB3 Receptor Signaling in Mutant BRAF Melanoma.
Academic Article MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.
Academic Article Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.
Academic Article Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Academic Article Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma.
Academic Article Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo.
Academic Article 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
Academic Article Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
Academic Article ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
Academic Article Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling.
Academic Article The next generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.
Academic Article Consecutive Case Series of Melanoma Sentinel Node Biopsy for Lymphoseek Compared to Sulfur Colloids.
Academic Article Precision Medicine in the Treatment of Melanoma.
Academic Article FOXD3 Regulates VISTA Expression in Melanoma.
Academic Article Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma.
Academic Article Margins of Melanoma Excision and Modifications to Standards.
Academic Article ASO Author Reflections: Gene Expression Profiling for Melanoma: Is it Ready for Prime Time?
Academic Article A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
Academic Article Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma.
Academic Article Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
Academic Article Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma.
Academic Article Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
Search Criteria
  • Melanoma